Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
20 Results for "
CDK3
" in MedChemExpress (MCE) Product Catalog:
Products (20)
20 Results for "CDK3" in MCE Product Catalog:
3
3 Cited Publications
RGB-286638 free base is a potent inhibitor of CDK and MAPK9. RGB-286638 free base inhibits the activities of cyclin T1-CDK9, cyclin B1-CDK1, cyclin E-CDK2, cyclin D1-CDK4, cyclin E-CDK3 and p35-CDK5, with IC50 values of 1, 2, 3, 4, 5 and 5 nM, respectively. RGB-286638 free base inhibits GSK-3β and TAK1, with IC50 values of 3 nM and 5 nM, respectively. RGB-286638 free base induces caspase-dependent Apoptosis in cells. RGB-286638 free base delays tumor growth in an orthotopic glioblastoma mouse model. RGB-286638 free base extends survival in multiple myeloma models. RGB-286638 free base can be used in research related to glioblastoma and multiple myeloma .
3
3 Cited Publications
RGB-286638 is a potent inhibitor of CDK and MAPK9. RGB-286638 inhibits the activities of cyclin T1-CDK9, cyclin B1-CDK1, cyclin E-CDK2, cyclin D1-CDK4, cyclin E-CDK3 and p35-CDK5, with IC50 values of 1, 2, 3, 4, 5 and 5 nM, respectively. RGB-286638 inhibits GSK-3β and TAK1, with IC50 values of 3 nM and 5 nM, respectively. RGB-286638 induces caspase-dependent Apoptosis in cells. RGB-286638 delays tumor growth in an orthotopic glioblastoma mouse model. RGB-286638 extends survival in multiple myeloma models. RGB-286638 can be used in research related to glioblastoma and multiple myeloma .
2
Roniciclib is an orally bioavailable pan-cyclin dependent kinase (CDK) inhibitor, with IC50s of 5-25 nM for CDK1, CDK2, CDK3, CDK4, CDK7 and CDK9.
Cat. No.: HY-142686A
Purity: 96.65%
Target:
Research Areas:
SGK1-IN-3 hydrochloride (Compound 3a) is an ATP-competitive SGK1 inhibitor with an IC50 of <1 nM against hSGK1. SGK1-IN-3 hydrochloride blocks the activity of CDK family members. SGK1-IN-3 hydrochloride serves as a P-glycoprotein substrate. SGK1-IN-3 can be used for the research of osteoarthritis .
Cat. No.: HY-RS02380
Target:
Research Areas:
CDK3 Human Pre-designed siRNA Set A contains three designed siRNAs for CDK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS18915
Target:
Research Areas:
Cdk3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cdk3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-E70678
CDK3 is a major player driving retinoblastoma (Rb) phosphorylation during the G0/G1 transition and in the early G1 phase of the cell cycle. CDK3 interacts with various transcription factors involved in cell proliferation, differentiation, and transformation driven by the EGFR/Ras signaling pathway. CDK3/CycE1 Recombinant Human Active Protein Kinase is an ortholog of CDK3 .
Cat. No.: HY-151878
CAS No.: 3034210-97-1
Research Areas:
CDK7-IN-20 is a potent, selective and irreversible CDK7 (CDK) inhibitor with an IC50 value of 4 nM. CDK7-IN-20 displays >206-fold selectivity for CDK7 over CDK1, CDK2, CDK3, CDK5, CDK6, CDK9 and CDK12 . CDK7-IN-20 has the potential for autosomal dominant polycystic kidney disease (ADPKD) research .
Cat. No.: HY-E70677
CDK3 is a major player driving retinoblastoma (Rb) phosphorylation during the G0/G1 transition and in the early G1 phase of the cell cycle. CDK3 interacts with various transcription factors involved in cell proliferation, differentiation, and transformation driven by the EGFR/Ras signaling pathway. CDK3/CycC Recombinant Human Active Protein Kinase is an ortholog of CDK3 .
Cat. No.: HY-E70680
CDK3 is a major player driving retinoblastoma (Rb) phosphorylation during the G0/G1 transition and in the early G1 phase of the cell cycle. CDK3 interacts with various transcription factors involved in cell proliferation, differentiation, and transformation driven by the EGFR/Ras signaling pathway. CDK3/CycO Recombinant Human Active Protein Kinase is an ortholog of CDK3 .
Cat. No.: HY-E70679
CDK3 is a major player driving retinoblastoma (Rb) phosphorylation during the G0/G1 transition and in the early G1 phase of the cell cycle. CDK3 interacts with various transcription factors involved in cell proliferation, differentiation, and transformation driven by the EGFR/Ras signaling pathway. CDK3/CycE2 Recombinant Human Active Protein Kinase is an ortholog of CDK3 .
Cat. No.: HY-161708
CAS No.: 3075001-08-7
PROTAC FLT3/CDKs degrader-1 is a PROTAC degrader targeting CDKs and FLT3. PROTAC FLT3/CDKs degrader-1 degrades CDK2, CDK4, CDK6, CDK9 and FLT3 proteins via a ubiquitin-proteasome-dependent bivalent mechanism, with a DC50 of 18.73 nM against CDK2. PROTAC FLT3/CDKs degrader-1 promotes myeloid cell differentiation. PROTAC FLT3/CDKs degrader-1 inhibits leukemia cell proliferation. PROTAC FLT3/CDKs degrader-1 can be used for the research of acute myeloid leukemia .
Cat. No.: HY-P703553
Purity: ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: CDK3; Cyclin-Dependent Kinase 3; Cyclin Dependent Kinase 3; Cyclin-Dependent Kinase; Cell Division Protein Kinase 3; CDKN3
Species:
Human
Source:
Sf9 insect cells
Cat. No.: HY-P702680
Purity: ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: CDK3; Cyclin-Dependent Kinase 3; Cyclin Dependent Kinase 3; Cyclin-Dependent Kinase; Cell Division Protein Kinase 3; CDKN3; CCNC; SRB11 Homolog; Cyclin C; HSRB11; Cyclin-C; CCNC Protein; CycC; SRB11
Species:
Human
Source:
Sf9 insect cells
Cat. No.: HY-P702681
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CDK3; Cyclin-Dependent Kinase 3; Cyclin Dependent Kinase 3; Cyclin-Dependent Kinase; Cell Division Protein Kinase 3; CDKN3; CCNE2; G1/S-Specific Cyclin-E2; Cyclin E2; Alternative Protein CCNE2; CYCE2; CCNE2 Protein
Species:
Human
Source:
Sf9 insect cells
Cat. No.: HY-161709
CAS No.: 2452019-67-7
Research Areas:
FLT3/CDKs ligand-1 (Compound 14) is a ligand for target protein, which promotes the degradation of cyclin-dependent kinase (CDK) and the FMS-like tyrosine kinase 3 (FLT3), inhibits FLT3/CDK related proliferations and survivals of leukemia cells. LT3/CDKs ligand-1 can be used for synthesis of PROTAC FLT3/CDKs degrader-1 (HY-161708) .
Cat. No.: HY-P701364
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CDK3; Cyclin-Dependent Kinase 3; Cyclin Dependent Kinase 3; Cyclin-Dependent Kinase; Cell Division Protein Kinase 3; CDKN3; CCNE1; Cyclin E Variant Ex7del; Prev. CCNE; Cyclin Et; G1/S-Specific Cyclin-E1; PCCNE1; Cyclin E Variant Ex5del; Cyclin E1; Cyclin
Species:
Human
Source:
Sf9 insect cells
Cat. No.: HY-P701365
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CDK3; Cyclin-Dependent Kinase 3; Cyclin Dependent Kinase 3; Cyclin-Dependent Kinase; Cell Division Protein Kinase 3; CDKN3; CCNE1; Cyclin E Variant Ex7del; Prev. CCNE; Cyclin Et; G1/S-Specific Cyclin-E1; PCCNE1; Cyclin E Variant Ex5del; Cyclin E1; Cyclin
Species:
Human
Source:
Sf9 insect cells
Cat. No.: HY-P706030
Purity: ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: CDK3; Cyclin-Dependent Kinase 3; Cyclin Dependent Kinase 3; Cyclin-Dependent Kinase; Cell Division Protein Kinase 3; CDKN3; CCNH; CycH; Cyclin H; Cyclin-Dependent Kinase-Activating Kinase Complex Subunit; P34; CDK-Activating Kinase Complex Subunit; P37; C
Species:
Human
Source:
Sf9 insect cells
Cat. No.: HY-P810605
Synonyms: CDK2; CDKN2; Cyclin-dependent kinase 2; Cell division protein kinase 2; p33 protein kinase
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
